 Recombinant virus vaccine-induced SIV-specific cytotoxic Evidence cytotoxic CTLs important spread human immunodeficiency virus HIV infected host use recombinant viruses approach protective immunity HIV ability recombinant viral constructs CTL primates live recombinant virus vaccinia-simian immunodeficiency virus macaques SIVmac lymphocyte-mediated antiviral response primate Vaccinia-SIVmac vaccination SIVmac Gag-specific CTL response rhesus monkeys CTLs peptide fragment Gag protein rhesus monkey major histocompatibility complex MHC class gene product CTL response vaccinated SIVmac-infected monkeys MHC class gene product CTLs Gag epitope specificity findings use recombinant virus vaccines prevention HIV infections humans